Femasys (FEMY) EBITDA (2020 - 2025)

Femasys has reported EBITDA for 6 years, with the latest figure at -$3.9 million in Q2 2025.

• For the quarter ending Q2 2025, EBITDA rose 14.07% year-over-year to -$3.9 million; the trailing twelve-month figure through Jun 2025 stood at -$19.2 million (down 16.25% YoY), and the FY2025 full-year result was -$17.6 million, up 1.11% from the prior year.
• EBITDA for Q2 2025 stood at -$3.9 million, up from -$5.5 million in the prior quarter.
• The five-year high for EBITDA was -$1.1 million in Q2 2021, with the low at -$5.5 million in Q1 2025.
• Historically, EBITDA has averaged -$3.4 million across 5 years, with a median of -$3.0 million in 2022.
• Annual changes were most pronounced in 2021 — EBITDA advanced 27.09% — and 2022, when it sank 145.6%.
• Femasys' EBITDA stood at -$2.4 million in 2021, then declined by 26.87% to -$3.0 million in 2022, then plunged by 48.3% to -$4.4 million in 2023, then declined by 6.14% to -$4.7 million in 2024, then increased by 18.44% to -$3.9 million in 2025.
• The last three EBITDA figures came in at -$3.9 million (Q2 2025), -$5.5 million (Q1 2025), and -$4.7 million (Q4 2024), per Business Quant data.